Our in-vitro diagnostic test kit based on rapid Polymerase Chain Reaction (PCR) amplification technology. This kit can reliably detect and distinguish the mutants from UK (20I/501Y.V1, B.1.1.7 – VOC-202012/01) as well as the South African mutation (B.1.351 lineage). The test kit is aimed to improve the public health situation by rapidly enabling the detection of variants of concern.
The kit is designed for quantitative detection of variants of interest of the SARS-CoV-2 Viral RNA in direct nasal, nasopharyngeal or throat swabs* and it works in conjuction with our peakPCR devices
* For Research Applications Only
The test kits are sold with all the necessary reagents pre-loaded in the reaction wells. The use of the test kits is therefore extremely simple:
Our test kits have undergone a preliminary validation at the Swiss Tropical and Public Health Institute (Swiss TPH).
Would you like to know more about our performance data and the validation of our kits? Please contact us!